Literature DB >> 4349022

Cyclic AMP: its effect on an estrogen-sensitive antigen in organ cultures of the cervicovaginal epithelium from neonatal mice.

S Kvinnsland, A Abro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4349022     DOI: 10.1007/bf01923168

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  4 in total

1.  Immunofluorescence studies on the effect of cyclic adenosine 3',5'-monophosphate in tissue cultue preparations of the cervicovaginal anlage from neonatal mice.

Authors:  D H Fjellestad; S Kvinnsland
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

2.  Action of cyclic adenosine 3',5'-monophosphate in vitro on the uptake and incorporation of uridine into ribonucleic acid in ovariectomized rat uterus.

Authors:  S K Sharma; G P Talwar
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

3.  Estrogen-like anabolic effects of cyclic 3',5'-adenosine monophosphate and other nucleotides in isolated rat uterus.

Authors:  O Hechter; K Yoshinaga; I D Halkerston; K Birchall
Journal:  Arch Biochem Biophys       Date:  1967-11       Impact factor: 4.013

4.  Preparation of antibody-ferritin conjugates for immunoelectron microscopy.

Authors:  J SRI RAM; S S TAWDE; G B PIERCE; A R MIDGLEY
Journal:  J Cell Biol       Date:  1963-06       Impact factor: 10.539

  4 in total
  3 in total

1.  Effect of propranolol on various parameters of estrogen stimulation in the rat uterus.

Authors:  A Tchernitchin; X Tchernitchin; A Rodríguez; M A Mena; C Unda; N Mairesse; P Galand
Journal:  Experientia       Date:  1977-11-15

2.  Adenylate cyclase in an estradiol sensitive tissue: a cytochemical study.

Authors:  A Abro; S Kvinnsland
Journal:  Histochemistry       Date:  1974

3.  Estradiol-17 beta and cAMP: in vitro studies on the cervicovaginal epithelium of neonatal mice.

Authors:  S Kvinnsland
Journal:  Cell Tissue Res       Date:  1976-12-10       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.